We report the case of a 71-year-old man with chronic myelomonocytic leukemia who developed cardiogenic shock twice due to a stenosis of the left main trunk of the coronary artery. We performed coronary artery bypass grafting to the left anterior descending artery with the left internal thoracic artery without using a cardiopulmonary bypass. The patient had no infection, leukemic transformation, or cardiac event after the surgery. Off-pump coronary artery bypass grafting is safe and useful for high risk patients, such as those with leukemia. (Jpn Heart J 2003; 44: 435-439) Key words: Less invasive cardiac surgery, Coronary artery bypass grafting without cardiopulmonary bypass, High risk patients WE performed off-pump coronary artery bypass grafting (OP-CAB) in a patient with chronic myelomonocytic leukemia (CMMoL) who developed cardiogenic shock twice due to left main coronary artery disease. CMMoL is a peculiar form of myelodysplastic syndrome, which is associated with a high mortality rate resulting from infection, 1) and has a characteristic form of interleukin-6 (IL-6) autocrine growth.
WE performed off-pump coronary artery bypass grafting (OP-CAB) in a patient with chronic myelomonocytic leukemia (CMMoL) who developed cardiogenic shock twice due to left main coronary artery disease. CMMoL is a peculiar form of myelodysplastic syndrome, which is associated with a high mortality rate resulting from infection, 1) and has a characteristic form of interleukin-6 (IL-6) autocrine growth.
2) OP-CAB has been reported to reduce the incidence of postoperative infection 3) and cytokine responses 3, 4) when compared with conventional revascularization with cardiopulmonary bypass (CPB).
CASE REPORT
A 71-year-old man with CMMoL was admitted to emergency for cardiogenic shock due to an acute myocardial infarction. Percutaneous transluminal coronary angioplasty (PTCA) was successfully performed at the lesion of the left main coronary artery trunk after insertion of an intra-aortic balloon. A percutaneous cardiopulmonary support system was not established because we were con-cerned about the condition of his leukemia. However, two months after the first PTCA, he again developed cardiogenic shock due to restenosis of the left main trunk. Although PTCA was undertaken successfully again, we decided to perform OP-CAB to prevent further cardiogenic shock due to restenosis of the same lesion.
A median sternotomy was performed. The left internal thoracic artery (LITA) was harvested. After ischemic preconditioning for 5 minutes, the LITA was anastomosed to the left anterior descending artery (LAD) using 8-0 Prolene (Ethicon, Somerville, NJ, USA.) on a beating heart. The circumflex system was not grafted because it was not well developed. The patient was extubated in the operating room and carried to the intensive care unit uneventfully.
A preoperative blood examination showed no abnormalities except increased white blood cells (WBC), anemia, and a slightly prolonged prothrombin time (Table) . The clinical course is summarized in Figure 1 . Cefazolin sodium (4 g per day) was administered for 5 days postoperatively. A bloody discharge from the chest tubes resulted in a decreased hematocrit value of 19.9%. The patient required blood product and was given 4 U of packed red blood cells and 6 U of fresh frozen plasma.
A postoperative LITA angiogram showed the LITA to LAD anastomosis was patent (Figure 2 ) and the patient was discharged with an uneventful conva- lescence. The patient is doing well without any cardiac events, infections, or leukemic transformation 6 months after the surgery.
DISCUSSION
Most patients with CMMoL are over 50 years of age at the time of diagnosis.
5) The onset is usually insidious, and the clinical symptoms include weakness, infection, or exaggerated bleeding. Most patients are diagnosed with anemia, a slightly decreased white cell count, and thrombocytopenia. When treating leukemic patients surgically, one must be concerned about 1) postoperative infections, 2) hemorrhaging, and 3) leukemic transformation.
One of the major concerns when performing cardiac surgery in patients with leukemia is postoperative infection because of their suppressed immune function. OP-CAB was reported to be associated with a significant reduction in postoperative infection compared with a conventional technique using CPB.
3) Samuels, et al 6) reported that the hospital mortality (17%) and morbidity (58%) are high and infectious complications (42%) are common when treating cardiac surgery patients with chronic leukocytic leukemia. In this case, we revascularized the LAD with a LITA conduit without any postoperative infection using only antibiotics. Gamma globulin and antifungal agents were ready to use if needed.
Care should be taken when surgically treating leukemic patiensts even if the preoperative bleeding and coagulation time are normal. Some blood transfusion was necessary to maintain a good circulation. The amount of chest drainage was larger compared with OP-CAB which is usually undertaken. Though the patient did not experience any clinical bleeding tendency, some hypocoagulability might have existed. However, this degree of transfusion would be acceptable considering the preoperative anemic state of the patient.
We must be concerned about leukemic transformations from a chronic phase to an accelerated phase and on to a blast crisis. IL-6 acts as an autocrine growth factor for CMMoL cells in vitro 2) and IL-6 production may be influenced by the degree of surgical trauma as well as by CPB-related factors. 4) All that can be done to reduce such cytokine responses is to avoid using CPB.
In summary, we performed OP-CAB rather than a conventional technique using CPB because OP-CAB has two benefits: 1) a decreased incidence of postoperative infections, and 2) a reduced cytokine response. OP-CAB was safe and useful in this patient with CMMoL.
